NCT06868069 Study on Blood Pressure Variability and Frailty in the Older People
| NCT ID | NCT06868069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Auxologico Italiano |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2024-07-15 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational prospective single-center, non-profit study. Primary objective of the study: To determine if the hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg) detected at Ambulatory Blood Pressure Monitoring (ABPM) is associated with adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)
Eligibility Criteria
Inclusion Criteria: * Age ≥ 75 years * Diagnosis of hypertension according to the criteria of the European Society of Cardiology guidelines \[Williams 2018\] * Consent of the patient (or legal representative) to participate in the study Exclusion Criteria: * Refusal of the patient or his/her legal representative * Life expectancy of less than 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06868069 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06868069 currently recruiting?
Yes, NCT06868069 is actively recruiting participants. Contact the research team at a.croce@auxologico.it for enrollment information.
Where is the NCT06868069 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06868069 clinical trial?
NCT06868069 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 220 participants.